Company: BIVIW
Filing Date: 2025-05-15
Form Type: DRS
Source: 0001520138-25-000149
Chunk: 70

Company: BIOVIE INC.
Filing Date: 2025-05-15
Form: DRS
Chunk 70
---
 $2.83
per share.

In connection with the October 28 Offering, the
Company issued the Placement Agent V Warrants, exercisable to purchase 57,300 shares of Common Stock, representing 5% of the October 28
Shares purchased at the closing of the October 28 Offering, for an aggregate purchase price of $100.00, at an exercise price of $3.5375
per share, which is equal to 125% of the October 28 Share Offering Price.

The holders of the Placement Agent V Warrants
may exercise the Placement Agent V Warrants by making a cash payment equal to the exercise price multiplied by the quantity of shares.
The holders of the Placement Agent V Warrants may also exercise the Placement Agent V Warrants on a cashless or “net issuance”
basis by receiving a net number of shares calculated pursuant to the formula set forth in the Placement Agent V Warrants. The Placement
Agent V Warrants are subject to anti-dilution adjustments for stock dividends, stock splits, and reverse stock splits. Pursuant to the
terms of the Placement Agent V Warrants, the holders of the Placement Agent V Warrants are entitled to piggyback registration rights if
the Company proposes to file a new registration statement under the Securities Act, subject to certain limitations.

Item 16. Exhibits

A list of the exhibits filed with this registration
statement on Form S-1 is set forth on the Exhibit Index and is incorporated herein by reference.

|         |     |                                                                                                                 |     | Incorporated by Reference |     |            |     |                   |     |             |     |                |
| Exhibit 
 No.     |     | Description                                                                                                     |     | Form                      |     | File No.   |     | Date Filed        |     | Exhibit No. |     | Filed Herewith |
| 1.1*    |     | Form of Underwriting Agreement                                                                                  |     |                           |     |            |     |                   |     |             |     |                |
| 2.1     |     | Agreement and Plan of Merger, dated April 11, 2016, among the Company, LAT Acquisition Corp and LAT Pharma, LLC |     | 8-K                       |     | 000-55292  |     | April 15, 2016*   |     |         2.1 |     |                |
| 3.1     |     | Articles of Incorporation of Company as filed with the